Owkin
Owkin is seeking a Forward Deployed Computational Biologist to design, build, and deploy production-grade AI solutions for complex scientific problems in collaboration with pharmaceutical and biotechnology companies. This hands-on, client-facing role involves translating ambiguous scientific challenges into reliable and scalable agentic solutions while bridging the gap between science and real-world application. The position requires frequent international travel and participation in a team-wide on-call rotation.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2016
Owkin is an AI biotech company that applies agentic reasoning and advanced machine learning to understand complex biology and accelerate biomedical research. Its platform — including the K Pro agentic decision-making tool for biopharma — combines privacy-preserving, federated-style approaches and predictive modeling to help discover biomarkers, optimize clinical trials, and support drug development. Owkin partners with hospitals, pharma companies, and research institutions and publishes scientific work while emphasizing AI ethics and responsible deployment. Their stated mission is to transform research toward a “biological artificial superintelligence” that improves patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Owkin.
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing
8 hours ago